131MIBG to Treat Malignant Pheochromocytoma
NCT00028106
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
32
Enrollment
NIH
Sponsor class
Conditions
Pheochromocytoma
Interventions
DRUG:
[131]I-MIBG
DRUG:
6-[18F]Fluorodopamine
DRUG:
[123]I-MIBG
Sponsor
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)